全文获取类型
收费全文 | 17763篇 |
免费 | 1062篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 209篇 |
儿科学 | 369篇 |
妇产科学 | 462篇 |
基础医学 | 2923篇 |
口腔科学 | 444篇 |
临床医学 | 1815篇 |
内科学 | 3220篇 |
皮肤病学 | 347篇 |
神经病学 | 1691篇 |
特种医学 | 901篇 |
外科学 | 2655篇 |
综合类 | 119篇 |
一般理论 | 2篇 |
预防医学 | 939篇 |
眼科学 | 580篇 |
药学 | 1207篇 |
中国医学 | 62篇 |
肿瘤学 | 934篇 |
出版年
2023年 | 70篇 |
2022年 | 117篇 |
2021年 | 277篇 |
2020年 | 157篇 |
2019年 | 298篇 |
2018年 | 339篇 |
2017年 | 288篇 |
2016年 | 350篇 |
2015年 | 366篇 |
2014年 | 503篇 |
2013年 | 730篇 |
2012年 | 990篇 |
2011年 | 987篇 |
2010年 | 676篇 |
2009年 | 637篇 |
2008年 | 976篇 |
2007年 | 1059篇 |
2006年 | 1068篇 |
2005年 | 1082篇 |
2004年 | 887篇 |
2003年 | 882篇 |
2002年 | 857篇 |
2001年 | 180篇 |
2000年 | 139篇 |
1999年 | 179篇 |
1998年 | 203篇 |
1997年 | 165篇 |
1996年 | 152篇 |
1995年 | 151篇 |
1994年 | 119篇 |
1993年 | 122篇 |
1992年 | 91篇 |
1991年 | 81篇 |
1990年 | 72篇 |
1988年 | 74篇 |
1985年 | 72篇 |
1984年 | 86篇 |
1983年 | 63篇 |
1982年 | 91篇 |
1981年 | 81篇 |
1933年 | 97篇 |
1932年 | 93篇 |
1931年 | 81篇 |
1930年 | 83篇 |
1929年 | 76篇 |
1928年 | 78篇 |
1927年 | 69篇 |
1926年 | 80篇 |
1924年 | 77篇 |
1923年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
There is a risk of myocardial ischemia in patients with pulmonary atresia and intact ventricular septum associated with right ventricle dependent coronary circulation, especially during open heart operation. Cardiopulmonary bypass unloads the right ventricle, and thereby reduces the coronary perfusion pressure in an area that is wholly or partly dependent on the right ventricle. We present a veno-venous bypass technique to keep the right ventricle beating and ejecting to supply the oxygenated blood into the right ventricle dependent myocardium and consequently to prevent myocardial ischemia during right heart bypass operation. 相似文献
152.
Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. 总被引:4,自引:0,他引:4
Markus Raderer Stefan W?hrer Rupert Bartsch Gerald Prager Johannes Drach Michael Hejna Alexander Gaiger Karl Turetschek Ulrich Jaeger Berthold Streubel Christoph C Zielinski 《Journal of clinical oncology》2005,23(33):8442-8446
PURPOSE: Various chemotherapeutic regimens have been applied for treatment of mucosa-associated lymphoid tissue (MALT) lymphoma, but no standard regimen has been identified to date. In view of the activity of oxaliplatin (L-OHP) in various types of lymphoma, we performed a phase II study to evaluate the activity of L-OHP for treatment of MALT lymphoma. The primary objective of this study was to determine the objective response rate according to WHO standard criteria. PATIENTS AND METHODS: A total of 16 patients with MALT lymphoma of various sites of origin (four of the ocular adnexa, five of the salivary glands, three of the stomach, two of the lung, and one of the colon and the breast) were administered L-OHP at a dose of 130 mg/m2 infused during 2 hours every 3 weeks. Restaging was performed every two cycles; treatment was continued until complete remission (CR) or for a maximum of six cycles in responders. RESULTS: Sixty-five cycles were administered (median, four; range, two to six); toxicity consisted of transient sensory neuropathy in eight patients and nausea/emesis WHO grade 2 in two patients, whereas hematologic adverse effects (thrombocytopenia and leukocytopenia grade 2) occurred in only one patient each. Fifteen patients responded to chemotherapy, with nine achieving CR (56%), six (37.5%) achieving partial response, and one achieving stable disease; the median time to response was 4 months (range; 2 to 4 months). CONCLUSION: These data suggest L-OHP is a highly active agent for treatment of MALT lymphoma. However, a longer follow-up is needed to judge whether these remissions are durable. 相似文献
153.
Sudhir Tauro Charles Craddock Karl Peggs Gulnaz Begum Premini Mahendra Gordon Cook Judith Marsh Donald Milligan Anthony Goldstone Ann Hunter Asim Khwaja Raj Chopra Timothy Littlewood Andrew Peniket Anne Parker Graham Jackson Geoff Hale Mark Cook Nigel Russell Stephen Mackinnon 《Journal of clinical oncology》2005,23(36):9387-9393
PURPOSE: The toxicity of allogeneic stem-cell transplantation can be substantially reduced using a reduced-intensity conditioning (RIC) regimen. This has increased the proportion of patients with myeloid malignancies eligible for allogeneic transplantation. However, the capacity of RIC allografts to produce durable remissions in patients with acute myeloid leukemia (AML) and myelodysplasia (MDS) has not yet been defined, and consequently, the role of RIC allografts in the management of these diseases remains conjectural. PATIENTS AND METHODS: Seventy-six patients with high-risk AML or MDS received an allograft using a fludarabine/melphalan RIC regimen incorporating alemtuzumab. The median age of the cohort was 52 years (range, 18 to 71 years). RESULTS: The 100-day transplantation-related mortality rate was 9%, and no patient developed greater than grade 2 graft-versus-host disease. With a median follow-up of 36 months (range, 13 to 70 months), 27 patients were alive and in remission, with 3-year actuarial overall survival (OS) and disease-free survival (DFS) rates of 41% and 37%, respectively. The 3-year OS and DFS rates of patients with AML in complete remission at the time of transplantation were 48% and 42%, respectively. Disease relapse was the most common cause of treatment failure and occurred at a median time of 6 months after transplantation. All but one patient destined to relapse did so within 24 months of transplantation. CONCLUSION: The extended follow-up in this series identifies a high risk of early disease relapse but provides evidence that RIC allografts can produce sustained DFS in a significant number of patients with AML who would be ineligible for allogeneic transplantation with myeloablative conditioning. 相似文献
154.
A. Danielle Iuliano Joan M. Brunkard Tegan K. Boehmer Elisha Peterson Stacey Adjei Alison M. Binder Stacy Cobb Philip Graff Pauline Hidalgo Mark J. Panaggio Jeanette J. Rainey Preetika Rao Karl Soetebier Susan Wacaster ChinEn Ai Vikas Gupta Noelle-Angelique M. Molinari Matthew D. Ritchey 《MMWR. Morbidity and mortality weekly report》2022,71(4):146
155.
156.
Joan SK Ng FRCS William Wong FRCP Ricky WK Law FRCS Joannie Hui MRCP Esther N Wong MRCP Dennis SC Lam FRCOphth 《Clinical & experimental ophthalmology》2001,29(4):239-243
Purpose : To investigate ocular complications arising from nephrotic syndrome and/or its treatments in children. Methods : A cross‐sectional study was conducted in a teaching hospital. A total of 31 paediatric patients with nephrotic syndrome were studied. Comprehensive ophthalmic assessments on best‐corrected visual acuity, intraocular pressure, slit‐lamp and fundus examination were taken. Information regarding histological diagnosis of nephrotic syndrome and its treatment regimen in each patient was reviewed and analysed. Results : Bilateral posterior subcapsular cataracts were detected in three of 29 patients (10.3%) who received steroid therapy. Two had normal vision while one had visual acuity reduced to 6/15 in both eyes. The age of onset of the nephrotic syndrome in these three patients was 2 years, which was significantly younger than those without cataract (5.4 ± 3.2 years, P < 0.001). Three patients (9.7%) had isolated asymptomatic fundal findings of tortuous and dilated retinal vessels. Hypertensive retinopathy was found in one patient (3.2%). No steroid‐induced glaucoma, uveitis, ocular infection, or other eye complications related to the use of steroids or other immunosuppressive agents were noted. Conclusions : Children who have nephrotic syndrome often require prolonged, intermittent high dose of systemic corticosteroid therapy. Paediatricians should be aware of the potential risk of developing steroid‐related complications, especially posterior subcapsular cataract. It appears to have a higher risk when steroid therapy is used in very young patients. Early detection would help to prevent amblyopia development, particularly in the group of immature eyes. 相似文献
157.
158.
Berthold Pemp Randy H. Kardon Karl Kircher Elisabeth Pernicka Ursula Schmidt-Erfurth Andreas Reitner 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2013,251(7):1841-1848
Background
Automated detection of subtle changes in peripapillary retinal nerve fibre layer thickness (RNFLT) over time using optical coherence tomography (OCT) is limited by inherent image quality before layer segmentation, stabilization of the scan on the peripapillary retina and its precise placement on repeated scans. The present study evaluates image quality and reproducibility of spectral domain (SD)-OCT comparing different rates of automatic real-time tracking (ART).Methods
Peripapillary RNFLT was measured in 40 healthy eyes on six different days using SD-OCT with an eye-tracking system. Image brightness of OCT with unaveraged single frame B-scans was compared to images using ART of 16 B-scans and 100 averaged frames. Short-term and day-to-day reproducibility was evaluated by calculation of intraindividual coefficients of variation (CV) and intraclass correlation coefficients (ICC) for single measurements as well as for seven repeated measurements per study day.Results
Image brightness, short-term reproducibility, and day-to-day reproducibility were significantly improved using ART of 100 frames compared to one and 16 frames. Short-term CV was reduced from 0.94?±?0.31 % and 0.91?±?0.54 % in scans of one and 16 frames to 0.56?±?0.42 % in scans of 100 averaged frames (P?≤?0.003 each). Day-to-day CV was reduced from 0.98?±?0.86 % and 0.78?±?0.56 % to 0.53?±?0.43 % (P?≤?0.022 each). The range of ICC was 0.94 to 0.99. Sample size calculations for detecting changes of RNFLT over time in the range of 2 to 5 μm were performed based on intraindividual variability.Conclusion
Image quality and reproducibility of mean peripapillary RNFLT measurements using SD-OCT is improved by averaging OCT images with eye-tracking compared to unaveraged single frame images. Further improvement is achieved by increasing the amount of frames per measurement, and by averaging values of repeated measurements per session. These strategies may allow a more accurate evaluation of RNFLT reduction in clinical trials observing optic nerve degeneration. 相似文献159.
160.
Reidar Bredo Sund Karl Songedal Toril Harestad Bjarne Salvesen Sidsel Kristiansen 《Basic & clinical pharmacology & toxicology》1981,48(1):73-80
Abstract: Bisacodyl (BIS), the parent diphenol (DES) and its sulphuric acid di-ester (picosulphate = PICO) were given by stomach tube to fasted rats at a dose of 3.1 μmol/100 g rat. Bile was sampled in the periods 0–6, 6–12 and 12–18 hrs after drug administration, and assayed for total diphenol (= free + conjugated) by HPLC. Mean fractions (% of dose±S.E.M.) excreted in 5 rats per compound and period were: BIS 74.0±4.7, 51.9±7.9 and 30.8±2.5; DES 41.2±4.3, 46.8±4.7 and 25.1±2.5; PICO 9.0±0.9, 26.0±5.4 and 19.6±3.1. Only minor amounts were excreted as free diphenol. Urine samples taken by bladder puncture and assayed as above furthermore showed that the renal excretion of total diphenol was insignificant compared to the amounts excreted in bile. Practically no diphenol was present in urine 0–6 hrs after the administration of PICO. In experiments with BIS and DES at 0.85 μmol/100 g, total diphenol excreted in bile during 0–6 hrs was: BIS 67.1±2.6 (n = 5); DES: 55.4±3.0 (5). - The latency time for laxative effect was studied in groups of 10 unfasted rats per compound. Cumulative time response curves showed that PICO caused diarrhoea more promptly at 0.85 μmol/100 g than either BIS or DES. In most rats, this delayed action of BIS and DES persisted also at 1.7 μmol/100 g. At 3.1 μmol/100 g, however, the majority of the rats reacted as promptly to these two compounds as to PICO. These results are discussed in relation to the biliary excretion experiments, and interpreted in terms of the relative importance at the different dose levels of: 1. The enterohepatic recirculated fraction, and 2. The non-absorbed fraction, which passes directly to the large intestine. For PICO, the latter fraction is the single determinant of the effect, which is triggered when the di-ester is being hydrolyzed to active diphenol in this part of the GI-tract. 相似文献